Skip to Main Content Skip to Site Map Skip to Accessibility Statement

Lung Cancer

Trial CONCORDE
Cancer Type Lung Cancer
Hospital(s) Belfast City Hospital
Information

A platform study of DNA damage response inhibitors in combination with conventional radiotherapy in non small cell lung cancer

Click Here to view Cancer Research UK trial summary
Trial REFINE-Lung
Cancer Type Lung Cancer
Hospital(s) Altnagelvin Hospital
Information

A randomised open-label phase III trial of Reduced Frequency pembrolizumab immuNothErapy for first-line treatment of patients with advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm frequency-response optimisation design

Click Here to view Cancer Research UK trial summary
Trial TOURIST Platform Trial
Cancer Type Lung Cancer
Hospital(s) Altnagelvin Hospital
Information

Thoracic Umbrella Radiotherapy Study in stage IV NSCLC